Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
María Eva Mingot-CastellanoMariana Canaro HirnykBlanca Sánchez-GonzálezMaría Teresa Álvarez-RománAbelardo Bárez-GarcíaÁngel Bernardo-GutiérrezSilvia Bernat-PabloEstefanía Bolaños-CalderónNora Viviana ButtaGonzalo Caballero-NavarroIsabel Socorro Caparrós-MirandaLaura Entrena-UreñaLuis Fernando Fernández-FuertesLuis Javier García-FradeMaría Del Carmen Gómez Del CastilloTomás José González-LópezCarlos Grande-GarcíaAriane Unamunzaga ZilaurrenIsidro Jarque-RamosReyes Jiménez-BárcenasElsa López-AnsoarDaniel Martínez-CarballeiraVioleta Martínez-RoblesEmilio Monteagudo-MontesinosJose Antonio ParamoMaría Del Mar Perera-ÁlvarezInmaculada Soto-OrtegaDavid Valcárcel-FerreirasCristina Pascual-Izquierdonull nullPublished in: Journal of clinical medicine (2023)
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.